Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Adobe
ADBE
|
+$593M |
| 2 |
Tesla
TSLA
|
+$473M |
| 3 |
Nike
NKE
|
+$403M |
| 4 |
AstraZeneca
AZN
|
+$401M |
| 5 |
Airbnb
ABNB
|
+$347M |
Top Sells
| 1 |
Amazon
AMZN
|
+$897M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$578M |
| 3 |
Moderna
MRNA
|
+$457M |
| 4 |
Aon
AON
|
+$410M |
| 5 |
Apple
AAPL
|
+$401M |
Sector Composition
| 1 | Technology | 20.43% |
| 2 | Healthcare | 20.23% |
| 3 | Consumer Staples | 11.18% |
| 4 | Consumer Discretionary | 9.83% |
| 5 | Industrials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Sarepta Therapeutics
SRPT
$1.82B
| $786K | ﹤0.01% |
8,500
-119,478
| -93% | -$11M |
|
|
YQ
2677
17 Education & Technology Group
YQ
$23.7M
| $786K | ﹤0.01% |
+43,665
| New | +$786K |
|
|
AHG
2678
Akso Health Group
AHG
$1.05B
| $785K | ﹤0.01% |
350,598
+24,014
| +7% | +$53.8K |
|
2679
Noodles & Co
NDLS
$30.7M
| $785K | ﹤0.01% |
+66,519
| New | +$785K |
|
2680
PROS Holdings
PRO
$699M
| $784K | ﹤0.01% |
+22,100
| New | +$784K |
|
2681
Cass Information Systems
CASS
$565M
| $781K | ﹤0.01% |
18,659
-45,726
| -71% | -$1.91M |
|
2682
Venus Concept
VERO
$4.33M
| $778K | ﹤0.01% |
1,878
-693
| -27% | -$287K |
|
|
ATC
2683
DELISTED
Atotech Limited
ATC
| $777K | ﹤0.01% |
32,191
-129,467
| -80% | -$3.12M |
|
2684
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.81B
| $776K | ﹤0.01% |
+20,400
| New | +$776K |
|
2685
Ranger Energy Services
RNGR
$298M
| $771K | ﹤0.01% |
83,789
-13,401
| -14% | -$123K |
|
2686
Electro-Sensors
ELSE
$16.4M
| $768K | ﹤0.01% |
152,700
-9,200
| -6% | -$46.3K |
|
2687
iShares Expanded Tech Sector ETF
IGM
$8.98B
| $767K | ﹤0.01% |
11,400
-9,000
| -44% | -$606K |
|
2688
SPDR Bloomberg 1-10 Year TIPS ETF
TIPX
$1.74B
| $766K | ﹤0.01% |
+36,300
| New | +$766K |
|
2689
iShares Russell 3000 ETF
IWV
$16.9B
| $765K | ﹤0.01% |
+3,000
| New | +$765K |
|
|
LOAN
2690
Manhattan Bridge Capital
LOAN
$61.3M
| $765K | ﹤0.01% |
112,528
-32,163
| -22% | -$219K |
|
2691
Synchronoss Technologies
SNCR
$66.9M
| $765K | ﹤0.01% |
35,414
-59,081
| -63% | -$1.28M |
|
2692
Stereotaxis
STXS
$260M
| $764K | ﹤0.01% |
+142,100
| New | +$764K |
|
2693
Lesaka Technologies
LSAK
$362M
| $763K | ﹤0.01% |
164,079
-34,100
| -17% | -$159K |
|
|
PLAN
2694
DELISTED
Anaplan, Inc.
PLAN
| $761K | ﹤0.01% |
12,500
-553,400
| -98% | -$33.7M |
|
2695
Vanguard Financials ETF
VFH
$12.9B
| $760K | ﹤0.01% |
8,200
+2,900
| +55% | +$269K |
|
2696
Virco
VIRC
$126M
| $759K | ﹤0.01% |
221,266
-22,602
| -9% | -$77.5K |
|
2697
Ambac
AMBC
$413M
| $756K | ﹤0.01% |
+52,800
| New | +$756K |
|
2698
Xtant Medical Holdings
XTNT
$82.2M
| $756K | ﹤0.01% |
680,800
-331,200
| -33% | -$368K |
|
2699
IDEAYA Biosciences
IDYA
$2.16B
| $755K | ﹤0.01% |
29,600
-39,000
| -57% | -$995K |
|
2700
Perspective Therapeutics
CATX
$258M
| $753K | ﹤0.01% |
119,363
-138,667
| -54% | -$875K |
|